Myasthenia gravis onset during rheumatic disease: a new paradoxical effect of anti-TNF alpha therapy? [electronic resource]
Producer: 20160201Description: 375-6 p. digitalISSN:- 1756-185X
- Anti-Inflammatory Agents -- adverse effects
- Arthritis, Psoriatic -- diagnosis
- Biological Products -- adverse effects
- Drug Substitution
- Etanercept -- adverse effects
- Humans
- Immunocompromised Host
- Male
- Middle Aged
- Myasthenia Gravis -- chemically induced
- Remission Induction
- Risk Factors
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.